Temporal reverse flow by proximal femoral artery occlusion during drug-coated balloon dilatation: a technique to minimize downstream particle embolization and systemic adverse effects

Downstream paclitaxel particle embolization for nonhealing ischemic ulcers and systemic adverse effects caused by a paclitaxel drug-coated balloon are of concern, and safety measures to prevent these adverse risks are needed. To reduce distal particle embolization and movement of the paclitaxel part...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Masayoshi Kimura, MD, Jun Shiraishi, MD, PhD, Masayuki Hyogo, MD, Takahisa Sawada, MD, PhD
Formato:	article
Lenguaje:	EN
Publicado:	Elsevier 2021
Materias:	Peripheral artery disease Critical limb ischemia Superficial femoral artery Drug-coated balloon Downstream embolization Surgery RD1-811 Diseases of the circulatory (Cardiovascular) system RC666-701
Acceso en línea:	https://doaj.org/article/e657be46651a449c890a97ee75d696c3
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:e657be46651a449c890a97ee75d696c3
record_format	dspace
spelling	oai:doaj.org-article:e657be46651a449c890a97ee75d696c32021-11-10T04:31:15ZTemporal reverse flow by proximal femoral artery occlusion during drug-coated balloon dilatation: a technique to minimize downstream particle embolization and systemic adverse effects2468-428710.1016/j.jvscit.2021.10.001https://doaj.org/article/e657be46651a449c890a97ee75d696c32021-12-01T00:00:00Zhttp://www.sciencedirect.com/science/article/pii/S2468428721001702https://doaj.org/toc/2468-4287Downstream paclitaxel particle embolization for nonhealing ischemic ulcers and systemic adverse effects caused by a paclitaxel drug-coated balloon are of concern, and safety measures to prevent these adverse risks are needed. To reduce distal particle embolization and movement of the paclitaxel particles to systemic blood flow during drug-coated balloon inflation, proximal balloon occlusion using a sheathless temporary occlusion balloon-guiding catheter and extraction by manual aspiration of the paclitaxel-containing blood through the catheter are good treatment options to overcome these risks. Here, we introduce this method with tips and tricks, and demonstrate initial experience of this technique.Masayoshi Kimura, MDJun Shiraishi, MD, PhDMasayuki Hyogo, MDTakahisa Sawada, MD, PhDElsevierarticlePeripheral artery diseaseCritical limb ischemiaSuperficial femoral arteryDrug-coated balloonDownstream embolizationSurgeryRD1-811Diseases of the circulatory (Cardiovascular) systemRC666-701ENJournal of Vascular Surgery Cases and Innovative Techniques, Vol 7, Iss 4, Pp 763-767 (2021)
institution	DOAJ
collection	DOAJ
language	EN
topic	Peripheral artery disease Critical limb ischemia Superficial femoral artery Drug-coated balloon Downstream embolization Surgery RD1-811 Diseases of the circulatory (Cardiovascular) system RC666-701
spellingShingle	Peripheral artery disease Critical limb ischemia Superficial femoral artery Drug-coated balloon Downstream embolization Surgery RD1-811 Diseases of the circulatory (Cardiovascular) system RC666-701 Masayoshi Kimura, MD Jun Shiraishi, MD, PhD Masayuki Hyogo, MD Takahisa Sawada, MD, PhD Temporal reverse flow by proximal femoral artery occlusion during drug-coated balloon dilatation: a technique to minimize downstream particle embolization and systemic adverse effects
description	Downstream paclitaxel particle embolization for nonhealing ischemic ulcers and systemic adverse effects caused by a paclitaxel drug-coated balloon are of concern, and safety measures to prevent these adverse risks are needed. To reduce distal particle embolization and movement of the paclitaxel particles to systemic blood flow during drug-coated balloon inflation, proximal balloon occlusion using a sheathless temporary occlusion balloon-guiding catheter and extraction by manual aspiration of the paclitaxel-containing blood through the catheter are good treatment options to overcome these risks. Here, we introduce this method with tips and tricks, and demonstrate initial experience of this technique.
format	article
author	Masayoshi Kimura, MD Jun Shiraishi, MD, PhD Masayuki Hyogo, MD Takahisa Sawada, MD, PhD
author_facet	Masayoshi Kimura, MD Jun Shiraishi, MD, PhD Masayuki Hyogo, MD Takahisa Sawada, MD, PhD
author_sort	Masayoshi Kimura, MD
title	Temporal reverse flow by proximal femoral artery occlusion during drug-coated balloon dilatation: a technique to minimize downstream particle embolization and systemic adverse effects
title_short	Temporal reverse flow by proximal femoral artery occlusion during drug-coated balloon dilatation: a technique to minimize downstream particle embolization and systemic adverse effects
title_full	Temporal reverse flow by proximal femoral artery occlusion during drug-coated balloon dilatation: a technique to minimize downstream particle embolization and systemic adverse effects
title_fullStr	Temporal reverse flow by proximal femoral artery occlusion during drug-coated balloon dilatation: a technique to minimize downstream particle embolization and systemic adverse effects
title_full_unstemmed	Temporal reverse flow by proximal femoral artery occlusion during drug-coated balloon dilatation: a technique to minimize downstream particle embolization and systemic adverse effects
title_sort	temporal reverse flow by proximal femoral artery occlusion during drug-coated balloon dilatation: a technique to minimize downstream particle embolization and systemic adverse effects
publisher	Elsevier
publishDate	2021
url	https://doaj.org/article/e657be46651a449c890a97ee75d696c3
work_keys_str_mv	AT masayoshikimuramd temporalreverseflowbyproximalfemoralarteryocclusionduringdrugcoatedballoondilatationatechniquetominimizedownstreamparticleembolizationandsystemicadverseeffects AT junshiraishimdphd temporalreverseflowbyproximalfemoralarteryocclusionduringdrugcoatedballoondilatationatechniquetominimizedownstreamparticleembolizationandsystemicadverseeffects AT masayukihyogomd temporalreverseflowbyproximalfemoralarteryocclusionduringdrugcoatedballoondilatationatechniquetominimizedownstreamparticleembolizationandsystemicadverseeffects AT takahisasawadamdphd temporalreverseflowbyproximalfemoralarteryocclusionduringdrugcoatedballoondilatationatechniquetominimizedownstreamparticleembolizationandsystemicadverseeffects
_version_	1718440703006081024

Temporal reverse flow by proximal femoral artery occlusion during drug-coated balloon dilatation: a technique to minimize downstream particle embolization and systemic adverse effects

Ejemplares similares